Cargando…
Letter to the Editor: Role of Ketamine in Vaso-Occlusive Crisis of Sickle Cell Disease
Autor principal: | Raghuraman, M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869265/ https://www.ncbi.nlm.nih.gov/pubmed/35283701 http://dx.doi.org/10.4103/sjmms.sjmms_234_21 |
Ejemplares similares
-
Vaso‐occlusive crisis in a patient with sickle cell trait and COVID‐19
por: Freitas, Luiz A. R., et al.
Publicado: (2021) -
Subdissociative-dose ketamine for sickle cell vaso-occlusive crisis: a narrative review for the emergency physician
por: Bawany, Mohammad H., et al.
Publicado: (2022) -
The Role of Infection in the Pathogenesis of Vaso-Occlusive Crisis in Patients with Sickle Cell Disease.
por: Ahmed, Sagir G.
Publicado: (2011) -
Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review
por: Alshahrani, Mohammed S., et al.
Publicado: (2021) -
Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management
por: Uwaezuoke, Samuel N, et al.
Publicado: (2018)